Contract Orientation and Kickoff Meeting
$3,500N01FY2024CANIH
University Of Illinois At Chicago, Chicago IL
Investigators
Abstract
The objective of the âPreclinical PREVENT Cancer Program: Toxicology and Pharmacology Testingâ IDIQ contracts will be to continue evaluation of the pharmacological and toxicological effects of potential cancer preventative agents. Resources from these contracts will be used to support development of several candidate cancer preventive agents.
View original record on NIH RePORTER →